ArticlePharmaceutics2025

Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer.

Yin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.